Mexiletine in a Newborn with Type 3 Long QT Syndrome: When Access is Difficult
Arq Bras Cardiol. 2022 May;118(5):989-991.
doi: 10.36660/abc.20210533.
[Article in
English,
Portuguese]
Affiliation
- 1 Universidade de São Paulo - Faculdade de Medicina Hospital das Clínicas - Instituto do Coração, São Paulo, SP - Brasil.
No abstract available
MeSH terms
-
Anti-Arrhythmia Agents / adverse effects
-
Electrocardiography
-
Humans
-
Infant, Newborn
-
Long QT Syndrome* / diagnosis
-
Long QT Syndrome* / drug therapy
-
Mexiletine* / therapeutic use
Substances
-
Anti-Arrhythmia Agents
-
Mexiletine